New research evaluates clinical trials investigating post-acute COVID-19 syndrome treatment

In a recent article published in Clinical Microbiology and Infection, researchers reviewed all registered trials currently investigating potential treatment options for post-acute coronavirus disease 2019 (COVID-19) syndrome (PACS).

More than 50 long-term effects of COVID-19: a systematic review and meta-analysis

A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndrome - ScienceDirect

Cell therapy strategies for COVID-19: Current approaches and potential applications

Long COVID (Post-COVID Conditions, PCC) > Fact Sheets > Yale Medicine

Paxlovid May Reduce Risk of Long Covid in Eligible Patients, Study Finds - The New York Times

Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19

Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes - eBioMedicine

Does BCG vaccination protect against acute respiratory infections and COVID- 19? A rapid review of current evidence - The Centre for Evidence-Based Medicine

Full article: Registered clinical trials investigating treatment of long COVID: a scoping review and recommendations for research

NIA-Funded Active Alzheimer's and Related Dementias Clinical Trials and Studies

Review of trials currently testing treatment and prevention of COVID-19 - ScienceDirect